ApproachCell therapy

NK and CAR-NK cells

Approach Europe PMC, retrieved 14 November 2026Inferred from the records, not an official entity

Kind: Approach
Topic: Cell therapy
What it covers: Natural killer cells, donor-derived or engineered with a chimeric antigen receptor (CAR-NK)